Eledon Pharmaceuticals, Inc. — Form D

Eledon Pharmaceuticals, Inc. of IRVINE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-27. The offering totals $5.8M, of which $862K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (40)

Showing 25 of 40 people.

NameRoleLocation
Erez ChimovitsDirectorNESS ZIONA, L3
Cheryl CohenDirectorSan Diego, CA
Gregory FlesherDirectorSan Diego, CA
Gregory FlesherExecutive OfficerSan Diego, CA
Jon KuwaharaExecutive OfficerIrvine, CA
CATHERINE TURKELExecutive OfficerKelowna, A1
John McBrideDirectorToronto, A6
June LeeDirectorBerkeley, CA
Bryan SmithExecutive OfficerNew York, NY
David KesslerDirectorTROY, MI
Keith A KatkinDirectorSan Diego, CA
Steven PerrinDirectorIrvine, CA
Steven PerrinExecutive OfficerIrvine, CA
David-Alexandre GrosDirectorIrvine, CA
David-Alexandre GrosExecutive OfficerIrvine, CA
Allan KirkDirectorIrvine, CA
James RobinsonDirectorMorrisville, NC
Keith KatkinDirectorIrvine, CA
Jan HillsonDirectorIrvine, CA
Paul LittleExecutive OfficerPine Ridge, SD
Walter OgierDirectorIrvine, CA
Reinhard J AmbrosDirectorWaltham, MA
Gary LyonsDirectorIrvine, CA
John A McBrideDirectorIrvine, CA
Steven N PerrinDirectorIrvine, CA

Other filings by this issuer (7)

FiledFormOfferingSold
2024-05-23D$50.0M
2023-05-22D$35.0M
2020-09-25D$108.1M$108.1M
2019-05-10D$28.5M$862K
2013-05-15D$35.5M$20.0M
2011-09-20D$23.0M$1.9M
2009-05-06D$22.0M$10.0M

More